Peer Review History

Original SubmissionDecember 7, 2020

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Gianpaolo Papaccio, Editor

PONE-D-20-38399

Naturally-derived protein biomaterials from Gryllus bimaculatus for improved antioxidant and stem cell differentiation

PLOS ONE

Dear Dr. Lim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Although of some interest, this manuscript and study needs to be considerably improved since the Title.

The pitfalls are numerous and include some methodological mistakes.

The Authors must follow all the criticisms raised by the two referees and amend the manuscript as requested.

Please submit your revised manuscript by Feb 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Gianpaolo Papaccio, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors aimed to investigate the effects of CPI on the osteogenic differentiation of hBMSCs.

The manuscript is interesting, but there are some points that must be clarified.

I suggest to improve the title. First of all, it is badly written in English. I suggest to use the word biopolymer instead of biomaterial. Biopolymers are polymers produced by living organisms. Cellulose, proteins, peptides, are all examples of biopolymers used in tissue engineering. For example, I suggest a possible title as following: "Naturally derived proteins extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs".

In figure 5a, the authors must report what the arrows indicate in the pictures.

The osteogenic differentiation must be evaluated also at 21 days .

The immunofluorescence showed in figure 8 (in particular for 2%CPI) is very bad. Dye deposits are detectable and the staining is aspecific. The Authors indicate these deposits as presence of CPI on surface of hBMSCs. How can the authors confirm this? If this is, it means that the CPI is not soluble. Incomplete solubility makes CPI difficult to use. Please, clarify better this point.

ALP must be performed using histological staining.

Moreover, the Authors stated that: “no significant difference was noted in the mean intensities among the control, and the CPI treated cells”.

In figure 8, the statistic is indicated using asterisks. This point must be clarified and reported in Results.

The Discussion must be revised, it is too long and dispersive.

Reviewer #2: 518 / 5000

Risultati della traduzione

Although the study was previously not sufficiently suitable for publication on Plos One, the experiments carried out by the authors following the suggestions of the reviewers, have significantly improved the paper.

Despite this, some concerns need to be addressed.

First of all, the title should be rewritten: it should be improved grammatically, with a verb that would make the meaning of the paper clearer.

Osteogenesis should also be evaluated at 21 days.

The discussion needs to be shortened.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers:

Reviewer 1:

The authors aimed to investigate the effects of CPI on the osteogenic differentiation of hBMSCs. The manuscript is interesting, but there are some points that must be clarified.

Author’s response: Thank you very much for reviewing our manuscript. We have made the necessary corrections based on your valuable suggestion.

Comment #1. I suggest to improve the title. First of all, it is badly written in English. I suggest to use the word biopolymer instead of biomaterial. Biopolymers are polymers produced by living organisms. Cellulose, proteins, peptides, are all examples of biopolymers used in tissue engineering. For example, I suggest a possible title as following: "Naturally derived proteins extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs".

Author’s response: Thank you for your kind recommendation. We agree with your suggested title and have updated the same in our revised manuscript.

[Naturally-derived protein extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs].

Comment #2. In figure 5a, the authors must report what the arrows indicate in the pictures.

Author’s response: Thank you for your comment. We have indicated the necessary information in the revised manuscript.

[Fig. 5. In vitro cytotoxicity evaluation of CPI on hBMSCs after 3 days of incubation. (a) optical microscopy images after Giemsa staining (b) fluorescence microscopy images of F-actin. The white arrows indicate the presence of stained CPI on the surface of hBMSCs].

Comment #3. The osteogenic differentiation must be evaluated also at 21 days.

Author’s response: Thank you very much for your suggestion. We have included the hBMSC differentiation using the ARS staining procedure (Fig. 5.) and immunohistochemistry of ALP expression (Fig. 6.) for 7, 14, and 21 days in our revised manuscript.

Comment #4. The immunofluorescence showed in figure 8 (in particular for 2%CPI) is very bad. Dye deposits are detectable and the staining is aspecific. The Authors indicate these deposits as presence of CPI on surface of hBMSCs. How can the authors confirm this? If this is, it means that the CPI is not soluble. Incomplete solubility makes CPI difficult to use. Please, clarify better this point.

Author’s response: Thank you very much for deeply reviewing our manuscript. We agree with your opinion. The CPI used in this study is partially soluble in DMEM at the physiological pH and hence some of the aggregated structure are visible on the surface of the cultured hBMSCs. To confirm the aggregates as CPI, we have taken the bright field images of the cells after desired treatment and is indicated in Supplementary Fig. 3 of the revised manuscript. Thus, the fluorescence microscopy images taken at different time period also indicates the presence of CPI aggregates on the surface of cells as shown in Fig. 8. We completely agree that soluble protein is more convenient for cellular interaction or metabolism. However, the purpose of our study was to check the potential of crude CPI on hBMSCs osteogenic potential at physiological pH. The size and the colloidal stability of the up to 2% CPI at physiological pH was found to favor hBMSCs growth and differentiation. Based on our study, we conclude that the use of up to 2% crude CPI is favorable for hBMSCs growth.

Comment #5. ALP must be performed using histological staining. Moreover, the Authors stated that: “no significant difference was noted in the mean intensities among the control, and the CPI treated cells”.

Author’s response: Thank you very much for your suggestion. We have included the immunohistochemistry staining of ALP after 7, 14, and 21 days of CPI treatment. As the protein expression for ALP was performed using the immunocytochemistry analysis, we could confirm the successful expression of the protein in both the treated and the control cells, indicating the CPI treatment favored the expression of the osteogenic marker proteins similar to control cells.

Comment #6. In figure 8, the statistic is indicated using asterisks. This point must be clarified and reported in Results.

Author’s response: Thank you for your kind information. We have discussed this point in the “Results” section in our revised manuscript.

Comment #7. The Discussion must be revised, it is too long and dispersive.

Author’s response: Thank you for your suggestion. We have updated the discussion in our revised manuscript as per your recommendation. 

Reviewer 2:

Risultati della traduzione

Although the study was previously not sufficiently suitable for publication on Plos One, the experiments carried out by the authors following the suggestions of the reviewers, have significantly improved the paper. Despite this, some concerns need to be addressed.

Comment #1. First of all, the title should be rewritten: it should be improved grammatically, with a verb that would make the meaning of the paper clearer.

Author’s response: Thank you very much for your valuable comment. We have changed the title in the revised manuscript as follows:

[Naturally-derived protein extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs].

Comment #2. Osteogenesis should also be evaluated at 21 days.

Author’s response: Thank you very much for your comment. We have evaluated the osteogenesis through ARS staining procedure for hBMSCs mineralization quantification (Fig. 5.) and ALP expression through immunohistochemistry (Fig. 6.) for 7, 14, and 21 days in the revised manuscript.

Comment #3. The discussion needs to be shortened.

Author’s response: Thank you very much for your kind recommendation. Based on your suggestion, we have shortened the discussion section in the revised manuscript.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Gianpaolo Papaccio, Editor

Naturally-derived protein extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs

PONE-D-20-38399R1

Dear Dr. Lim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gianpaolo Papaccio, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Gianpaolo Papaccio, Editor

PONE-D-20-38399R1

Naturally-derived protein extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs

Dear Dr. Lim:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Gianpaolo Papaccio

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .